| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 |
| filingDate |
2006-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47b6b244532e156ce4f2a03773b2b555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71ce3bcce5b7ab29d5ad2274455d5f2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01200633b0e2f05acfb18dbbfb8af8e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55619184cc38ad176b3f1e223a8ddc8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baa90709488f858c4859174b8e3453b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57b151068c90dc1e6e9c95c59d541704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e2bda4b10ff731f2a4126dd8924ca41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b79e898ffd0ce59e9f99759a49ed0a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82a8508b1f3a253bdf9c6d5963759e6e |
| publicationDate |
2007-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1863833-A2 |
| titleOfInvention |
Process for preparing macrocyclic compounds |
| abstract |
Disclosed is a process for preparing a macrocyclic compound of the formula (I) wherein a hydroxyl-substituted macrocyclic compound of formula (3) is reacted with a sulfonyl-substituted compound of formula QUIN. The compounds of formula (I) are potent active agents for the treatment of hepatitis C virus (HCV) infection. |
| priorityDate |
2005-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |